194 related articles for article (PubMed ID: 22911764)
21. Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma.
Koike N; Pilon-Thomas S; Mulé JJ
J Immunother; 2008 May; 31(4):402-12. PubMed ID: 18391755
[TBL] [Abstract][Full Text] [Related]
22. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
[TBL] [Abstract][Full Text] [Related]
23. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
[TBL] [Abstract][Full Text] [Related]
24. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
[TBL] [Abstract][Full Text] [Related]
25. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer.
Jaramillo A; Majumder K; Manna PP; Fleming TP; Doherty G; Dipersio JF; Mohanakumar T
Int J Cancer; 2002 Dec; 102(5):499-506. PubMed ID: 12432553
[TBL] [Abstract][Full Text] [Related]
26. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
27. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
28. Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.
Li L; Herndon JM; Truscott SM; Hansen TH; Fleming TP; Goedegebuure P; Gillanders WE
Vaccine; 2010 Feb; 28(8):1911-8. PubMed ID: 20188246
[TBL] [Abstract][Full Text] [Related]
29. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
[TBL] [Abstract][Full Text] [Related]
30. Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells.
Tiriveedhi V; Fleming TP; Goedegebuure PS; Naughton M; Ma C; Lockhart C; Gao F; Gillanders WE; Mohanakumar T
Breast Cancer Res Treat; 2013 Feb; 138(1):109-18. PubMed ID: 22678162
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
Ryan CM; Schell TD
J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic Activity and Memory T Cell Subset Distribution of
Kuznetsova M; Lopatnikova J; Shevchenko J; Silkov A; Maksyutov A; Sennikov S
Front Immunol; 2019; 10():1017. PubMed ID: 31143180
[TBL] [Abstract][Full Text] [Related]
33. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice.
Bullock TN; Colella TA; Engelhard VH
J Immunol; 2000 Mar; 164(5):2354-61. PubMed ID: 10679070
[TBL] [Abstract][Full Text] [Related]
34. Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways.
Rush C; Mitchell T; Garside P
J Immunol; 2002 Nov; 169(9):4951-60. PubMed ID: 12391208
[TBL] [Abstract][Full Text] [Related]
35. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
36. Enhanced responses to tumor immunization following total body irradiation are time-dependent.
Diab A; Jenq RR; Rizzuto GA; Cohen AD; Huggins DW; Merghoub T; Engelhorn ME; Guevara-Patiño JA; Suh D; Hubbard-Lucey VM; Kochman AA; Chen S; Zhong H; Wolchok JD; van den Brink MR; Houghton AN; Perales MA
PLoS One; 2013; 8(12):e82496. PubMed ID: 24349298
[TBL] [Abstract][Full Text] [Related]
37. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
Bristol JA; Schlom J; Abrams SI
Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
[TBL] [Abstract][Full Text] [Related]
38. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
[TBL] [Abstract][Full Text] [Related]
39. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
van der Waart AB; Fredrix H; van der Voort R; Schaap N; Hobo W; Dolstra H
Cancer Immunol Immunother; 2015 May; 64(5):645-54. PubMed ID: 25724840
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of Tissue-Specific CD8
Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
J Virol; 2018 May; 92(10):. PubMed ID: 29514902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
